FDA
-
-
-
-
-
-
-
FDA approves Sanofi's Tzield for children as young as one year old
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
-
-
-
-
-
-
-
Press release: Sanofi successfully prices USD 3 billion of bond issue
-
-
-
-
-
-
-
BofA sees attractive growth in this large-cap pharma stock
-
-
-
-
-
-
-
Sanofi (SNY) announces plans to invest $20 billion in the U.S. through 2030
-
-
-
-
-
-
-
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
-
-
-
-
-
-
-
Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment
-
325,441 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

